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ABSTRACT
Stepped wedge designs (SWDs) are designs for cluster randomized trials that feature staggered,
unidirectional cross-over, typically from a control to a treatment condition. Existing literature on
statistical power for SWDs primarily focuses on designs with a single treatment. However, SWDs
with multiple treatments are being proposed and conducted. We present a linear mixed model for a
SWD with two treatments, with and without an interaction between them. We derive closed form
solutions for the standard errors of the treatment effect coefficients for such models along with power
calculation methods. We consider repeated cross-sectional designs as well as open and closed cohort
designs and different random effect structures. Design features are examined to determine their
impact on power for main treatment and interaction effects.
Keywords stepped wedge design · factorial design · power calculation · clinical trial · design · cluster randomized trial
1 Introduction
Cluster randomized trials (CRTs) are trials in which groups of individuals, called clusters, are randomized to treatment
arms. CRTs can use parallel designs, in which clusters receive only one treatment, or crossover designs, in which
clusters are assigned to a sequence of treatments. A variation on the CRT crossover design is the stepped wedge design
(SWD) [1]. The most common SWDs involve unidirectional crossover in which clusters transition from a control
condition to a treatment condition at different pre-specified times. Clusters are randomized to the pre-determined
sequences. Typically, all clusters are in the treatment condition in the last period [2]. An example of such a SWD is
shown in Figure 1.
SWDs have several advantages over parallel and crossover CRT designs. SWDs allow comparisons both within cluster
and across cluster, which can yield efficiency gains [3]. It may be less costly and logistically easier to roll out the
intervention over time instead of all at once, as would occur in many parallel CRTs [4]. Guaranteeing treatment for all
clusters may make clusters more willing to participate or alleviate some ethical concerns [3].
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Figure 1: Example of a stepped wedge design with six clusters, four time periods, and one treatment. There are three
distinct sequences with two clusters in each sequence. A white cell indicates the control condition and a gray cell
represents the treatment condition.
Most research on the design and analysis of stepped wedge trials has focused on the SWD with one intervention
contrasted with a control condition. There is a small but growing body of literature on SWDs involving multiple
interventions. Grayling et al. [5] focus on studies in which there is a nested natural order of D interventions such
that intervention d consists of intervention d− 1 plus some additional factor. The authors discuss the optimization of
treatment sequence allocations and focus on optimal design for such trials. Variances for treatment effect estimates in
SWDs with nested interventions have also been studied [6]. The limited existing literature does not include modeling of
a potential interaction between treatments [7].
SWDs with multiple interventions are being implemented in practice despite a lack of methodological literature. For
example, a recently funded trial of the comparative effectiveness of two interventions to promote human papillomavirus
(HPV) vaccination is using a stepped wedge design implemented at seven clinics over a four-year period [8]. One
intervention is a parent reminder sent via text message, and the other is a multi-component clinic-based intervention
comprised of staff education, workflow modifications, and regular auditing. The study combines the stepped wedge
design with a 2 × 2 factorial design, with cluster-periods in a control condition, single intervention conditions for
both treatments, and a combined condition in which clinics receive both interventions. In another example, the
STARSHIP study examined two treatments to assess their efficacy in reducing hyperbilirubinaemia in infants [9].
The study employed a SWD with two treatments and a combined condition where a clinic receives both treatments
simultaneously. The STARSHIP study assumed additive treatment effects and did not consider an interaction effect.
Lyons et al. identified additional studies that employed SWDs with more than one treatment [7]. One such example is
the SSTP-ACT study that compared two behavioral health interventions with the goal of reducing behavioral problems
in children with cerebral palsy [10]. Similar to the STARSHIP study, the SSTP-ACT study had a combined condition
where clusters can receive both treatments simultaneously but did not include an interaction effect.
There are also examples in the literature of studies that conduct two one-treatment SWD trials simultaneously. The
FallDem study examined two interventions for improving the lives of dementia patients [7, 11]. Durovni et al. conducted
two SWD trials for tuberculosis screening [12, 13]. It is unclear whether the investigators of these studies considered
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combining the two separate SWDs into one larger SWD with two treatments. This might have allowed for more precise
estimates of treatment effects, direct comparisons of the treatments, and a possible reduction in the number of clusters
required to achieve the desired level of power.
In this paper, we consider SWDs with two treatments, with and without a combined condition, and with and without an
interaction effect. We call trials that include a combined condition stepped wedge factorial designs (SWFDs). As in
other 2× 2 factorial designs, these trials involve two factors, each with two levels, with four treatment combinations in
total. Factorial designs have several well-known advantages, such as potentially increased efficiency and the ability to
study interaction effects [14]. We derive analytical results for conducting power analysis for such trials and examine
factors that influence power.
The paper is organized as follows. Section 2 introduces the models for the SWD with two treatments including the
SWFD model and develops power analysis methods. Section 3 uses illustrative examples to examine the influence of
different design features on power. Section 4 discusses our findings, possible extensions, limitations and future work.
2 Methods
We first present models for SWDs with two treatments, with and without an interaction term, assuming a repeated
cross-sectional study design in which outcomes are assessed on different individuals within each cluster in each time
period. We then discuss cohort designs, in which outcomes are measured on some or all of the same individuals in a
cluster across time periods, and the nested exchangeable model, which relaxes some assumptions. We standardize the
models to allow power calculations to be conducted by specifying intracluster correlation (ICC) and autocorrelation
values instead of variance components, which can be difficult to specify. Power for both main effects and an interaction
effect are considered. The section concludes with an overview of the derivation of closed form solutions for the standard
errors of the estimated treatment effect coefficients, with the full derivation found in Appendix A.
2.1 Cross-Sectional Design
We begin with a model for a single binary treatment factor and a repeated cross-sectional design, as originally proposed
by Hussey and Hughes [1]. For a design with I clusters observed at T times, and N different individuals per time per
cluster, let Yijk be a continuous outcome for for individual k in cluster i at time j. The model for Yijk is
Yijk = µ+ αi + βj +Xijθ1 + eijk (1)
where µ is an intercept, αi ∼ N(0, σ2α) is a random intercept for cluster i, βj is a fixed effect for time j, Xij is a {0,1}
indicator for whether cluster i at time j receives treatment, θ1 is the treatment effect, and eijk ∼ N(0, σ2e). The total
variance of an individual level outcome is σ2y = σ
2
α + σ
2
e .
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This model can easily be expanded to accommodate multiple binary treatment factors. Assuming additive treatment
effects, the model with two treatment conditions is
Yijk = µ+ αi + βj +Xijθ1 +Wijθ2 + eijk, (2)
where Wij is a {0,1} indicator of whether cluster i at time j receives treatment 2 and θ2 is the treatment effect
for treatment 2. Adding an interaction effect to accommodate trials in which a cluster can receive both treatments
simultaneously, the model becomes
Yijk = µ+ αi + βj +Xijθ1 +Wijθ2 +XijWijθ3 + eijk, (3)
where θ3 is the interaction effect.
In these models, the correlation between outcomes of two different individuals k and k′ in the same cluster i at the
same time j, Corr(yijk, yijk′), is commonly termed the intracluster correlation (ICC). We denote this ICC as ρw. It
can be shown that ρw = σ2α/σ
2
Y . These models also imply that the correlation between two observations on different
individuals in the same cluster and same time period is equal to the correlation between two observations in the same
cluster but different time periods, i.e., Corr(yijk, yijk′) = Corr(yijk, yij′k′). We denote the latter correlation as ρa and
note that the repeated cross-sectional model assumes ρw = ρa.
To standardize one of these models, one can divide it through by σy. The cluster random intercept αi now has
standardized variance ρw and the error term has standardized variance 1− ρw. Standardization is convenient for power
calculations because only ρw needs to be specified rather than both σ2e and σ
2
α.
To derive standard errors, it is convenient to work with cluster-level outcomes. Let Y ij· = 1N
∑N
k=1 Yijk be the mean
outcome of cluster i at time j across N individuals. The model for cluster-period means is
Y ij· = µ+ αi + βj +Xijθ1 +Wijθ2 +XijWijθ3 + eij·, (4)
where eij· = 1N
∑N
k=1 eijk ∼ N(0, σ2c ) and σ2c = σ
2
e
N . Under this model, the variance of a cluster-period mean is
Var(Y ij·) = σ2c + σ
2
α. Define the outcome vector Y = (Y 11·, . . . , Y iT ·, . . . , Y I1·, . . . , Y IT ·)
′. Assuming clusters are
independent, the variance-covariance matrix of Y is a IT × IT matrix of the form
V =

V1 0 0 0
0 V2 . . . 0
0 0
. . . 0
0 0 . . . VI
 ,
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with each T × T matrix Vi having structure
Vi =

σ2α + σ
2
c σ
2
α . . . σ
2
α
σ2α σ
2
α + σ
2
c . . . σ
2
α
...
...
. . .
...
σ2α σ
2
α . . . σ
2
α + σ
2
c
 .
In the standardized model, Vi will have diagonal elements ρw + (1 − ρw)/N and off-diagonal elements ρw. Now
we turn to the design matrix of the fixed effects. Setting βT = 0 for identifiability [1], the (T + 3) × 1 regression
coefficient vector for the fixed effects is
η =
[
µ β1 . . . βT−1 θ1 θ2 θ3
]′
.
Then, the full IT × (T + 3) design matrix Z becomes
Z =
[
Z1 Z2 . . . ZI
]′
.
Each matrix Zi has dimension T× (T+3) and takes the form
Zi =
1T IT−1
0
′
T−1
Xi Wi (XW )i
 .
The elements of the vectorXi = (Xi1, Xi2, . . . , XiT )′ are indicators of whether cluster i at time j receives treatment
1, the elements ofWi = (Wi1,Wi2, . . . ,WiT )′ are indicators of receipt of treatment 2, and (XW )i is the Hadamard
product of Xi andWi, with a value of 1 if cluster i receives both treatments at time j and 0 otherwise. The matrix
IT−1 contains indicators for each time j from 1, . . . , (T − 1). The vector 0′T−1 corresponds to time T .
2.2 Cohort Design
When an individual can be observed at more than one time period, we must account for the correlation between
observations from the same individual. This can be accomplished by adding a random intercept ψik ∼ N(0, σ2ψ) for
individual k in cluster i to the cross-sectional model (3), yielding
Yijk = µ+ αi + βj +Xijθ1 +Wijθ2 +XijWijθ3 + ψik + eijk. (5)
The total variance of an individual level outcome in this model is σ2y = σ
2
α + σ
2
ψ + σ
2
e . The correlation between two
observations in the same cluster and same time period, Corr(yijk, yijk′), k 6= k′, is ρw = σ2α/σ2Y , and the correlation
5
A PREPRINT - OCTOBER 7, 2020
between two observations on the same individual k at times j and j‘, Corr(yij′k, yijk), j 6= j′, is ρa = (σ2α + σ2ψ)/σ2Y .
Note that ρa ≥ ρw.
Individual auto-correlation (IAC) is defined as the proportion of the individual-level variance (which in this model
is σ2ψ + σ
2
e ) that is time-invariant. In this model, the IAC is pi = σ
2
ψ/(σ
2
ψ + σ
2
e). Setting pi = 0 yields a repeated
cross-sectional design. By allowing pi to vary between 0 and a specified maximum value for individuals followed
throughout the entire study, this model can handle studies with a mixture of cross-sectional and cohort observations for
power calculations [15, 16], including open cohort designs in which individuals can enter and/or depart during the study
period [17].
Dividing the model by σY , we obtain the standardized variance of αi as ρw = σ2α/σ
2
Y . Using the definition of the IAC
and the fact that the standardized variances sum to 1, we obtain the standardized variance of ψik as pi(1− ρw) and the
standardized variance of the error term as 1− ρw − pi(1− ρw). Thus we can specify all standardized variances in terms
of ρw and pi, which is convenient for power calculations.
In this model, the cluster-period means are equal to
Y ij· = µ+ αi + βj +Xijθ1 +Wijθ2 +XijWijθ3 + ψi + eij , (6)
where ψi = 1N
∑N
k=1 ψik ∼ N(0,
σ2ψ
N ). The variance-covariance matrix of the cluster-period means for cluster i is
Vi =

σ2α + σ
2
c +
σ2ψ
N σ
2
α +
σ2ψ
N . . . σ
2
α +
σ2ψ
N
σ2α +
σ2ψ
N σ
2
α + σ
2
c +
σ2ψ
N . . . σ
2
α +
σ2ψ
N
...
...
. . .
...
σ2α +
σ2ψ
N σ
2
α +
σ2ψ
N . . . σ
2
α + σ
2
c +
σ2ψ
N
 .
In the standardized model, the matrix Vi has diagonal elements ρw + (1 − ρw)/N and off-diagonal elements ρw +
pi(1− ρw)/N .
2.3 Nested Exchangeable Correlation Model
The repeated cross-sectional model (3) assumes the correlation between two observations in the same cluster and same
time period is equal to the correlation between two observations in the same cluster but different time periods, i.e.,
ρw = ρa. Using the approach in Hemming et al. [2], one can allow these value to differ by adding a random effect νij
for cluster i in time j, yielding the model
Yijk = µ+ αi + βj +Xijθ1 +Wijθ2 +XijWijθ3 + νij + eijk, (7)
6
A PREPRINT - OCTOBER 7, 2020
in which νij ∼ N(0, σ2ν) is assumed independent of eijk and αi. In this model, σ2y = σ2ν + σ2α + σ2e . This approach
divides the cluster-level variance into time-varying and time invariant components, namely, σ2ν and σ
2
α. The within-
period ICC is now ρw = (σ2ν+σ
2
α)/σ
2
y and the across-period ICC is ρa = σ
2
α/σ
2
y. Let the cluster auto-correlation (CAC)
be the proportion of cluster level variance that is time-invariant [15, 16]. Then we have CAC = σ2α/(σ
2
ν+σ
2
α) = ρa/ρw.
The standardized variances of αi, νij and eijk are ρa, ρw − ρa and 1− ρw, respectively. Thus all variance components
can be expressed in terms of ρw and ρa. Note that we must have ρw ≥ ρa.
Under this model, cluster-period means take the form
Y ij· = µ+ αi + βj +Xijθ1 +Wijθ2 +XijWijθ3 + νij + eij· (8)
and the variance-covariance matrix for cluster i is
Vi =

σ2α + σ
2
c + σ
2
ν σ
2
α . . . σ
2
α
σ2α σ
2
α + σ
2
c + σ
2
ν . . . σ
2
α
...
...
. . .
...
σ2α σ
2
α . . . σ
2
α + σ
2
c + σ
2
ν
 .
In the standardized model, Vi has diagonal elements ρw + (1− ρw)/N and off-diagonal elements ρa.
2.4 Power Analysis
Inference for fixed effects in linear mixed models can be conducted using Wald tests or likelihood ratio tests. We focus
on Wald tests. For hypotheses of the form H0 : η = 0, where η is a fixed effects coefficient, the Wald test statistic
takes the form ηˆ/
√
Var(ηˆ), where ηˆ is the estimated coefficient, and has an approximate standard normal distribution
when the null is true [18]. The power to reject H0 for a specific true value of η, denoted ηa, with type I error rate α is
approximately
P
( ∣∣∣∣∣ ηa√Var(ηˆ)
∣∣∣∣∣ ≥ z1−α2 ∣∣∣ η = ηa
)
where z1−α2 is the corresponding (1− α2 )th percentile of the standard normal distribution.
To calculate power, we need an expression for Var(ηˆ). We derive expressions for Var(ηˆ) for each of the three models
using the cluster-period mean models in (4), (6) and (8). Given that these are linear mixed models, the variance-
covariance matrix of the estimated fixed effect coefficients takes the form C = (Z
′
V −1Z)−1, where Z is the fixed
effects design matrix and V is the variance-covariance matrix of the outcome vector. We are most interested in finding
expressions for the variances and covariances of treatment effect coefficient estimates, θˆ1, θˆ2, and θˆ3. We find an
expression for Z
′
V
−1
Z then invert it to get the elements of (Z
′
V
−1
Z)−1 corresponding to these variances and
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covariances. We focus on the repeated cross-sectional model here; the derivation generalizes to the cohort and nested
exchangeable models by using the appropriate structure of the matrix V .
LetZ be the IT×(T+3) design matrix and V be the IT×IT variance-covariance matrix of the cluster-level outcomes.
Assuming clusters are independent, the matrix V has block diagonal structure with elements Vi = σ2cIT + σ
2
α1T 1
′
T ,
where IT is a T × T identity matrix and 1T is a T × 1 vector of 1’s. Using the Sherman-Morrison formula [19, 20],
we can obtain its inverse as
Vi
−1 =
1
σ2c (σ
2
c + Tσ
2
α)
[
(σ2c + Tσ
2
α)IT − σ2α1T 1T ′
]
.
This matrix has off-diagonal elements −σ
2
α
σ2c(Tσ
2
α+σ
2
c)
and diagonal elements (T−1)σ
2
α+σ
2
c
σ2c(Tσ
2
α+σ
2
c)
. Due to the block diagonal
structure of V , we have
Z′V −1Z =
I∑
i=1
Zi
′Vi−1Zi,
where Zi is the T × (T + 3) part of the design matrix corresponding to cluster i. We can then rewrite
Zi
′Vi−1Zi =
1
σ2c (σ
2
c + Tσ
2
α)
[
(σ2c + Tσ
2
α)Zi
′Zi − σ2αZi′1T 1T ′Zi
]
. (9)
We then use block matrix inversion techniques to solve for the submatrix corresponding to the coefficients corresponding
to the treatment and interaction effects. A full derivation is provided in Appendix A.
3 Illustrative Examples
Although we derived closed form solutions for the variance and covariances of the treatment and interaction effect
estimates, there is no simple, intuitive expression for the standard errors nor for power. We therefore use numerical
examples to illustrate how power for detecting treatment and interaction effects is affected by design features for
SWDs with two treatments. All calculations were performed in R version 3.6.1 [21] with code available on Github at
https://github.com/phillipsundin/SWFD.
Our main concerns are how power is impacted by the assignment of cluster-periods to conditions and by the factorial
aspect of designs. We focus attention on cluster-period assignments that are likely to be used in practice. For example,
we only consider designs in which a combined condition follows a control condition or a single treatment condition.
We do not consider designs in which a cluster can transition from a combined to a single treatment condition, or from
one single treatment to the other single treatment, because such designs are vulnerable to contamination and therefore
would not be commonly used. We also focus on designs with relatively few clusters, which is common in practice [22].
8
A PREPRINT - OCTOBER 7, 2020
For simplicity, we use the repeated cross-sectional design for our examples. Power for repeated cross-sectional versus
cohort designs is not a focus of our paper and has been addressed by others [16]. In general, cohort designs have higher
power than cross-sectional designs [23, 24]. Often, ICCs are reported as the within-time, within-cluster correlation, ρw;
the across-time, within-cluster correlation ρa and individual auto-correlation pi are not always reported. Given this lack
of information, it may be sensible to make the simplifying assumption that ρw = ρa, which corresponds to the repeated
cross-sectional design.
3.1 Two-Treatment Concurrent SWD vs Two Separate Single Treatment SWDs
Several studies have conducted two separate one-treatment SWD trials [11, 12]. We explore how power might be
increased or the required number of clusters reduced by combining two one-treatment trials into one trial with two
treatments.
Consider the two one-treatment SWD trials, each with six clusters and four time periods, illustrated in Figure 2a. The
design in Figure 2b combines these into a single 12-cluster trial; such a design has been called a concurrent design [7].
Figure 2c shows a similar concurrent design with only 10 clusters. Let δ1 and δ2 denote the standardized effect sizes for
treatments 1 and 2, respectively. We set δ1 = δ2 = 0.4, representing medium effect sizes [25]. Note that within each
design, the power to detect treatment effects 1 and 2 is the same due to symmetry. We specify N = 15 individuals per
cluster-period in a repeated cross-sectional design. Power for detecting a treatment effect in one of the one-treatment
SWDs is calculated using model (1); for the concurrent SWDs with two treatments, power is calculated using model (2).
(a) Two separate single treatment
SWDs
(b) Concurrent SWD with two treatments,
12 clusters
(c) Concurrent SWD with two treatments,
10 clusters
Figure 2: Examples of two one-treatment SWDs versus concurrent SWDs with two treatments. White cells indicate cluster-periods
in the control condition. Light and dark gray cells indicate treatment conditions for treatments 1 and 2, respectively.
Figure 3 displays power for either treatment effect for the three designs as a function of ρw. Combining the two
one-treatment SWDs into a single concurrent design while maintaining the same number of clusters yields a large gain
in power, ranging from 0.14 to 0.20 for the values of ρw considered. The concurrent design with only ten clusters
reduces the sample size by about 17% and has moderately higher power, ranging from 0.08 to 0.11. Further reducing
9
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Figure 3: Comparing power for either treatment effect for two simultaneous one-treatment SWDs, a concurrent SWD
with two treatments with 12 clusters, and a concurrent SWD with two treatments with 10 clusters.
the number of clusters while maintaining symmetry would yield lower power than the single treatment SWDs in this
example.
In addition to power gains and reduced sample size requirements, another advantage of including two treatments in one
SWD is the capability to directly compare the two interventions. This can be accomplished using tests of linear contrasts
of treatment effects. A closed form solution for the standard error of such contrasts, which includes a covariance term,
can be computed using our methods. Suppose we wish to detect a standardized difference of 0.4 units between the two
treatments. Figure 4 displays power for the linear contrast as a function ρw. The relationship between ρw and power for
the linear contrast is similar in shape to the relationship between ρw and power for detecting main effects. However, the
nadir of the power curve is at a higher value of ρw (about 0.12) for the linear contrast in this example.
Figure 4: Comparing power for detecting a difference between two treatments for a 12-cluster concurrent SWD and a
10-cluster concurrent SWD.
3.2 Stepped Wedge Factorial Designs with Additive Treatment Effects
We now consider using designs with a combined condition to estimate additive treatment effects. We contrast the
12-cluster concurrent design in Figure 2b with SWFDs that feature some cluster-periods receiving both treatments
simultaneously. While many designs are possible, for illustrative purposes we consider the two designs in Figure 5.
Figure 5a shows a 12-cluster “late" factorial design in which all clusters transition to the combined condition for the
last period. Figure 5b shows an “earlier" factorial design with only ten clusters that introduces the combined condition
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earlier. Both designs feature six cluster-periods in each single treatment condition and twelve cluster-periods in the
combined condition, representing equal intervention resources. Treatment effects are assumed to be additive. Other
design aspects, including repeated cross-sectional observations, moderate effect sizes (δ1 = δ2 = 0.4) and N = 15 for
each cluster-period, are assumed to be the same.
(a) "Late" factorial design with 12 clusters in which
every cluster receives the combined condition in the
last (fourth) period
(b) "Earlier" factorial design with 10 clusters, in which two
clusters begin receiving the combined condition in the third period
Figure 5: Stepped Wedge Factorial Design Examples.
Figure 6 compares power for the three designs (Figures 2b, 5a and 5b) as a function of ρw. For ρw < 0.02, the 12-cluster
concurrent design and the 10-cluster “earlier" factorial design have similar power while the 12-cluster “late" factorial
design has the lowest power. For ρw > 0.02, the power of the 10-cluster “earlier" design is highest; the 12-cluster “late"
design continues to have the lowest power.
Figure 6: Comparing power for a 12-cluster concurrent design, a factorial design with 10 clusters, and a factorial design
with 12 clusters.
This example illustrates several points. First, when the treatment effects are additive, including a combined condition
has the potential to increase efficiency and reduce the number of clusters required to achieve a desired level of power.
However, the timing of transitions to the combined condition matters. Simply assigning all clusters to the combined
condition for the last period reduced power. Rather, the combined condition needed to be introduced in an earlier period
to realize efficiency gains. Furthermore, the value of the ICC is also important. Efficiency gains from using a SWFD
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were only realized when the ICC exceeded a certain value. A similar phenomenon has been found for a one-treatment
SWD compared to a parallel cluster randomized trial [26].
We can also compare the two treatments directly using the SWFD. Suppose we wish to detect a standardized difference
of 0.4 between the two treatment conditions. Figure 7 shows that is this example, the concurrent design has the highest
power for detecting this contrast across all values of ρw. For low values of ρw, the two factorial designs have similar
power, but for ρw > 0.10, the design with 12 clusters has about 7% higher power compared to the 10-cluster design.
This example shows that for hypotheses comparing treatments, introducing a combined condition is likely to reduce
power compared to a concurrent design. Introducing a combined condition decreases both the variances and covariance
of the two treatment effect estimates; however, the covariance tends to decrease at a much faster rate than the variances
as the number of cluster-periods in the combined condition is increased. Because Var(θˆ1 − θˆ2) = Var(θˆ1) + Var(θˆ2)−
2Cov(θˆ1, θˆ2), the higher covariance values in the concurrent design will result in a smaller overall variance for the
contrast, and thus higher power, compared to most SWFDs. This result may seem counterintuitive, since factorial designs
are associated with efficiency gains for testing linear contrasts in the context of independent units of randomization.
However, note that we still see efficiency gains for testing main effects with this factorial design.
Figure 7: Comparing power for detecting a difference between two treatments for the concurrent and factorial designs.
3.3 Stepped Wedge Factorial Designs with Interaction Effect
We now consider designs in which detecting an interaction is of interest. Consider the four designs in Figure 8. All
have eight clusters, as well as seven cluster-periods in treatment 1 only, seven cluster-periods in treatment 2 only,
and ten cluster-periods in the combined condition. Design #1 is essentially a concurrent design in which each cluster
transitions from control to one condition only during the study, including the combined condition. Design #2 has three
clusters transitioning from control to treatment 1 to combined, three clusters transitioning from control to treatment 2 to
combined, and two clusters transitioning from control to a single treatment condition relatively late in the study. Design
#3 has six of the eight clusters transition to a single treatment in classic stepped wedge style, and all clusters transition
to the combined condition. Design #4 is similar but includes two clusters that never transition to the combined condition
as well as combined condition clusters that start earlier.
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Design #1 Design #2
Design #3 Design #4
Figure 8: Varying sequences in a stepped wedge factorial design.
We again assume a repeated cross-sectional design with 15 individuals per cluster-period. We calculate power to
detect a standardized effect size of 0.60 for each main and interaction effect. Because this represents a relatively large
interaction effect, this example illustrates how design choices impact power for an interaction effect.
Figure 9 presents power as a function of ρw for the four designs. Note that Designs #1, #3, and #4 are symmetric in
treatments 1 and 2 and thus power for these two treatment effects is the same in these designs. Design #2 is close to
symmetric, but symmetry may be hard to achieve with a small number of clusters. We focus first on power for main
effects, displayed in Figure 9a. For all values of ρw, Design #2 has the highest power for detecting main effects. In this
design, power for treatment 1 is slightly higher than that for treatment 2. This result is attributable to a more balanced
sequencing of treatment 1 over time compared to treatment 2, as the majority of cluster-periods with only treatment 2
are administered later in the study. For values of ρw < 0.06, Design #4 has the lowest power; for ρw > 0.06, Design #1
(concurrent) has the lowest power. Focusing on power for the interaction effect, displayed in Figure 9b, Design #2 has
by far the highest power, while Design #3 has the lowest power. Design #1 also has relatively low power.
Design #2 is clearly superior for detecting both main and interaction effects. In Design #2, clusters transition between
conditions more than any other design. When there are more transitions, within-cluster comparisons are increased,
and thus power to detect effects is increased. Design #1 does not have any clusters transition to different treatment
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(a) Main Effects (b) Interaction Effect
Figure 9: Comparing main and interaction effects for SWFDs with different sequences.
conditions after the first transition from the control condition, and thus suffers from the lowest power for main effects.
For the interaction effect, Design #3 suffers from the lowest power. This can be partially attributed to confounding
with time, as all of the clusters are in the combined condition during the last time period, and there are only two
cluster-periods in the combined condition before the last time period.
This example illustrates that to power on the interaction term, designs should include (1) clusters that transition from
control to single treatment to the combined condition and (2) transitions to the combined condition should occur
relatively early in the study. Our examples also show that power for both main and interactions effect in SWFDs has
a non-monotone relationship with ρw, with the lowest power for values of ρw between 0 and 0.2, depending on the
particular design.
We note that in all of our examples, the power curves have had a non-monotone relationship with ρw, such that power is
a decreasing function of ρw at lower values of ρw and an increasing function at higher values. This is consistent with
power curves for stepped wedge designs with only one treatment [3, 26, 27].
4 Discussion
In this paper, we present power calculation methods for stepped wedge trials that involve two treatments, with and
without a combined condition or interaction. Designs with two treatments are increasingly being used in practice,
despite a paucity of literature on their statistical design and analysis.
We focus on studies that include a relatively small number of clusters, which is common for stepped wedge trials [22].
In our examples, it was not possible to explore all possible design options. However, the examples demonstrate several
principles. We show that a concurrent design, in which two one-treatment stepped wedge trials are conducted as a single
study, is more efficient than two separate one-treatment studies, and we enable power calculations for such studies.
In concurrent designs, cluster-periods in the control condition perform “double duty" by serving as controls for both
treatment conditions. Such trials are essentially three-arm trials in which two interventions are each compared to a
control condition.
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When designing trials with two treatment conditions, investigators may wish to consider the need to control the
experimentwise type I error rate. We note that a concurrent stepped wedge design is similar to a one-way analysis of
variance design in which multiple treatment groups are each compared to a common control group. In this setting,
Dunnett’s method may be used for experimentwise type I error rate control [28].
Our examples illustrate that factorial stepped wedge designs that include cluster-periods in a combined condition can
increase power substantially compared to concurrent designs when treatment effects are additive. However, power may
end up being inadequate if an interaction between treatments is manifested in the study but was not taken into account
in power calculations. One approach for guarding against this eventuality is to conduct sensitivity analyses that assume
some interaction between treatments when designing the study. Our proposed power calculation methods can be used
for this purpose.
Our models allow for an interaction between two treatments in a stepped wedge design. In many studies, detecting an
interaction effect may be of scientific interest. The presence of an interaction generally decreases power for detecting
main effects in factorial designs [29]. In a SWFD where the aims include detecting an interaction effect, treatment
sequencing is critical. Our examples show that in general, designs in which clusters transition from control to single
treatment to combined treatment will be more powerful than designs in which clusters make only one transition,
from control to single treatment or control to combined condition. Such multiple-transition designs allow for more
within-cluster comparisons, which are a driving factor in power for stepped wedge trials in general.
In this paper, we focus on SWDs with two treatments. However, if every condition can be represented by a binary
indicator, the results are generalizable to any number of treatments and two-way interactions. Consider a model with M
main effects and B two-way interaction terms. The variance-covariance matrix of the regression coefficients would
be a (M + B) × (M + B) matrix. The elements of this matrix would have the same form as the elements of the
3× 3 matrix in Appendix A for diagonal and off-diagonal elements for both main and interaction effects. Solving for
[(M + B) × (M + B)]−1 would yield the variance-covariance matrix for the estimated coefficients. Note that this
approach holds for two-way interactions only; higher-order interactions are not considered.
We consider continuous outcomes only. Further development is needed for non-continuous outcomes, including binary,
survival, categorical and count outcomes. For the nested exchangeable model in Section 2.3, the cluster autocorrelation
is constrained to be the same for cluster means across time periods, regardless of the length of time between observing
cluster level outcomes. This may not be an accurate assumption, as cluster means observed closer in time may be more
correlated than those that are farther apart [2]. There are models for one treatment SWDs that allow the correlation
between cluster means to decay over time [30, 31, 32]. For linear mixed models with a decaying correlation structure,
the covariance matrix is a Toeplitz matrix and requires the use of the Trench algorithm to numerically invert [31]. We
did not include this feature in our work here as we focused on the derivation of closed form variances and covariances
of treatment and interaction effects. In this paper, we only consider complete SWDs. Incomplete designs, in which for
some periods, data are not collected from some clusters, have been addressed for stepped wedge trials with a single
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treatment [33, 34]. Finally, we have assumed that treatment effects are instantaneous and do not consider any delay in
treatment effects, which have been considered for SWDs with a single treatment [1, 32, 35]. Future work could explore
how delays in one or both treatment effects may impact power of main and interaction effects.
Appendix A: Derivation of Standard Errors of Treatment Effect Estimates
The variance-covariance matrix of the fixed effects in a linear mixed model is found by taking the inverse of Z
′
V
−1
Z
in which Z is the fixed effects design matrix and V is the variance-covariance matrix of the outcome. In the SWFD
model presented in (4), Z is the IT × (T + 3) design matrix and V is the IT × IT variance-covariance matrix of
the outcome. We limit ourselves to finding closed form expressions only for the variance-covariance matrix of the
treatment effect estimates, θˆ1, θˆ2, and θˆ3. We first find an expression for Z
′
V
−1
Z and then use block matrix inversion
techniques to get the desired elements of (Z
′
V
−1
Z)−1.
Defining the Precision Matrix
We focus on the repeated cross-sectional model. For the nested exchangeable and cohort models, the appropriate values
for elements of V can be substituted.
Assuming that clusters are independent, for the repeated cross-sectional model, the matrix V has block diagonal
structure with elements Vi = σ2cIT + σ
2
α1T 1
′
T , where IT is a T × T identity matrix and 1T is a T × 1 vector of 1’s.
Using the Sherman-Morrison formula [19, 20] for the inverse of a matrix of this form, we obtain
Vi
−1 =
1
σ2c (σ
2
c + Tσ
2
α)
[
(σ2c + Tσ
2
α)IT − σ2α1T 1
′
T
]
.
Due to the the block diagonal structure of V , we can write the precision matrix as
Z
′
V
−1
Z =
I∑
i=1
Z
′
iVi
−1Zi.
The submatrix Zi is the T × (T + 3) subset of Z corresponding to cluster i. We then can write
Z
′
iVi
−1Zi =
1
σ2c (σ
2
c + Tσ
2
α)
[
(σ2c + Tσ
2
α)Z
′
iZi − σ2αZ
′
i1T 1
′
TZi
]
. (10)
In the following, the vectors X,W , andXW correspond to the columns of the design matrix corresponding to
treatment 1, treatment 2, and the interaction term, respectively. Further, letXi be the (T × 1) vector that corresponds
to cluster i, andXi,−T be the (T − 1)× 1 vector for cluster i that does not include the value ofXi at time T . We use
similar notation forWi andWi,−T for treatment 2, and we useXWi andXWi,−T for the interaction term. Using
the summation of submatrices in (10), we can write the precision matrix Z
′
V
−1
Z as a (T + 3)× (T + 3) symmetric
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matrix whose lower triangular elements are
Z
′
V −1Z =

Tf
f1T−1 (f + gT )IT−1 − g1T−11′T−1
y1
∑I
i=1
X
′
i,−T
σ2c
− σ2αh11
′
T−1 l1 − z1
y2
∑I
i=1
W
′
i,−T
σ2c
− σ2αh21
′
T−1 q1 l2 − z2
y3
∑I
i=1
(XW )
′
i,−T
σ2c
− σ2αh31
′
T−1 q2 q3 l3 − z3

.
The term 1T−1 is a (T − 1)× 1 vector of 1’s and IT−1 is a (T − 1) identity matrix, and we define
a =
1
σ2c + Tσ
2
α
, b =
1
σ2c
, c = ab, XT =
T∑
j=1
Xij , W
T =
T∑
j=1
Wij , (XW )
T =
T∑
j=1
XijWij ,
XIT =
I∑
i=1
T∑
j=1
Xij , W
IT =
I∑
i=1
T∑
j=1
Wij , (XW )
IT =
I∑
i=1
T∑
j=1
XijWij , f = Ia, g = Icσ
2
α,
y1 = aX
IT , y2 = aW
IT , y3 = a(XW )
IT , h1 = cX
IT h2 = cW
IT , h3 = c(XW )
IT , z1 = cσ
2
α
I∑
i=1
(XT )2,
z2 = cσ
2
α
I∑
i=1
(
WT
)2
, z3 = cσ
2
α
I∑
i=1
(
(XW )T
)2
, l1 = bX
IT , l2 = bW
IT , l3 = b(XW )
IT ,
q1 = l3 − cσ2α
I∑
i=1
(
XT
) (
WT
)
, q2 = l3 − cσ2α
I∑
i=1
(
(XW )T
) (
XT
)
, q3 = l3 − cσ2α
I∑
i=1
(
(XW )T
) (
WT
)
.
The terms q2 and q3 make use of the relationship X2ij = Xij and W
2
ij =Wij .
Blocking the Precision Matrix
The next step is to partition the precision matrix into a 2 × 2 block matrix. The matrix (Z ′V −1Z)11 is the T × T
submatrix, (Z
′
V −1Z)21 = (Z
′
V −1Z)
′
12 is the T × 3 submatrix and (Z ′V −1Z)22 is the 3 × 3 submatrix corre-
sponding to the precision of the parameters of interest: θˆ1, θˆ2, and θˆ3. Using block matrix inversion [36], we can find
the inverse of this submatrix as (Z ′V −1Z)−122 =
(
(Z ′V −1Z)22 − (Z ′V −1Z)21(Z ′V −1Z)−111 (Z ′V −1Z)12
)−1
.
We first obtain (Z ′V −1Z))−111 using another variation of block matrix inversion [36] and Schur complements, yielding
(Z ′V −1Z)−111 =
1
(f + gT )
 (g+f)f −1′T−1
−1T−1 (IT−1 + 1T−11′T−1)
 .
LetB = IT−1 + 1T−11
′
T−1 and letM = (Z
′V −1Z)21(Z ′V −1Z)−111 (Z
′V −1Z)12. Using matrix multiplication,
we can find
M =
1
(f+gT )

y1
∑I
i=1
X
′
i,−T
σ2c
−σ2αh11
′
T−1
y2
∑I
i=1
W
′
i,−T
σ2c
−σ2αh21
′
T−1
y3
∑I
i=1
(XW )
′
i,−T
σ2c
−σ2αh31
′
T−1

 (g+f)f −1′T−1
−1T−1 B


y1
∑I
i=1
X
′
i,−T
σ2c
−σ2αh11
′
T−1
y2
∑I
i=1
W
′
i,−T
σ2c
−σ2αh21
′
T−1
y3
∑I
i=1
(XW )
′
i,−T
σ2c
−σ2αh31
′
T−1

′
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=
1
(f+gT )

y1
∑I
i=1
X
′
i,−T
σ2c
−σ2αh11
′
T−1
y2
∑I
i=1
W
′
i,−T
σ2c
−σ2αh21
′
T−1
y3
∑I
i=1
(XW )
′
i,−T
σ2c
−σ2αh31
′
T−1


g+f
f
y1−1′T−1
(∑I
i=1
Xi,−T
σ2c
−σ2αh11T−1
)
−y11T−1+B
(∑I
i=1
Xi,−T
σ2c
−σ2αh11T−1
)
g+f
f
y2−1′T−1
(∑I
i=1
Wi,−T
σ2c
−σ2αh21T−1
)
−y21T−1+B
(∑I
i=1
Wi,−T
σ2c
−σ2αh21T−1
)
g+f
f
y3−1′T−1
(∑I
i=1
(XW )i,−T
σ2c
−σ2αh31T−1
)
−y31T−1+B
(∑I
i=1
(XW )i,−T
σ2c
−σ2αh31T−1
)

′
.
Solving for the −1′T−1
(∑I
i=1
Xi,−T
σ2c
−σ2αh11T−1
)
in the second matrix (similar for other elements), we obtain
=
T−1∑
i=j
I∑
i=1
Xij
σ2c
−hσ2α1T−1
′
1T−1
 =
T−1∑
i=j
I∑
i=1
Xij
σ2c
−σ2α(T−1)
I∑
i=1
T∑
j=1
Xij
σ2c (σ
2
c+Tσ
2
α)

=
 T∑
i=j
I∑
i=1
σ2cXij+Tσ
2
αXij
σ2c (σ
2
c+Tσ
2
α)
− σ
2
αTXij−σ2αXij
σ2c (σ
2
c+Tσ
2
α)
− I∑
i=1
XiT
σ2c
=
 T∑
i=j
I∑
i=1
Xij
(σ2c+Tσ
2
α)
+
 T∑
i=j
I∑
i=1
σ2αXij
σ2c (σ
2
c+Tσ
2
α)
− I∑
i=1
XiT
σ2c
= y1+σ
2
αh1−
I∑
i=1
XiT
σ2c
.
Substituting this term back intoM yieldsM = 1(f+gT )

m11 m12 m13
m21 m22 m23
m31 m32 m33
 with elements
m11 = y1
(
g+f
f
y1+
(
−y1−σ2αh1+
I∑
i=1
XiT
σ2c
))
+
(
I∑
i=1
X
′
i,−T
σ2c
−σ2αh11
′
T−1
)(
−y11T−1+B
(
I∑
i=1
Xi,−T
σ2c
−σ2αh11T−1
))
m12 = y1
(
g+f
f
y2+
(
−y2−σ2αh2+
I∑
i=1
WiT
σ2c
))
+
(
I∑
i=1
X
′
i,−T
σ2c
−σ2αh11
′
T−1
)(
−y21T−1+B
(
I∑
i=1
Wi,−T
σ2c
−σ2αh21T−1
))
m13 = y1
(
g+f
f
y3+
(
−y3−σ2αh3+
I∑
i=1
(XW )iT
σ2c
))
+
(
I∑
i=1
X
′
i,−T
σ2c
−σ2αh11
′
T−1
)(
−y31T−1+B
(
I∑
i=1
(XW )i,−T
σ2c
−σ2αh31T−1
))
m21 = y2
(
g+f
f
y1−
(
y1+σ
2
αh1−
I∑
i=1
XiT
σ2c
))
+
(
I∑
i=1
W
′
i,−T
σ2c
−σ2αh21
′
T−1
)(
−y11T−1+B
(
I∑
i=1
Xi,−T
σ2c
−σ2αh11T−1
))
m22 = y2
(
g+f
f
y2−
(
y2+σ
2
αh2−
I∑
i=1
WiT
σ2c
))
+
(
I∑
i=1
W
′
i,−T
σ2c
−σ2αh21
′
T−1
)(
−y21T−1+B
(
I∑
i=1
Wi,−T
σ2c
−σ2αh21T−1
))
m23 = y2
(
g+f
f
y3−
(
y3+σ
2
αh3−
I∑
i=1
(XW )iT
σ2c
))
+
(
I∑
i=1
W
′
i,−T
σ2c
−σ2αh21
′
T−1
)(
−y31T−1+B
(
I∑
i=1
(XW )i,−T
σ2c
−σ2αh31T−1
))
m31 = y3
(
g+f
f
y1−
(
y1+σ
2
αh1−
I∑
i=1
XiT
σ2c
))
+
(
I∑
i=1
XW
′
i,−T
σ2c
−σ2αh31
′
T−1
)(
−y11T−1+B
(
I∑
i=1
Xi,−T
σ2c
−σ2αh11T−1
))
m32 = y3
(
g+f
f
y2−
(
y2+σ
2
αh2−
I∑
i=1
WiT
σ2c
))
+
(
I∑
i=1
XW
′
i,−T
σ2c
−σ2αh31
′
T−1
)(
−y21T−1+B
(
I∑
i=1
Wi,−T
σ2c
−σ2αh21T−1
))
m33 = y3
(
g+f
f
y3−
(
y3+σ
2
αh3−
I∑
i=1
(XW )iT
σ2c
))
+
(
I∑
i=1
XW
′
i,−T
σ2c
−σ2αh31
′
T−1
)(
−y31T−1+B
(
I∑
i=1
(XW )i,−T
σ2c
−σ2αh31T−1
))
.
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Simplifying the diagonal elements ofM
The three diagonal elements ofM have the same form, so we will solve for the (1,1) element of the matrix corresponding
to treatment 1 and apply the form to all three diagonal elements. Let η1 = y1+σ2αh1−
∑I
i=1
XiT
σ2c
, then the diagonal
element is:
=
1
(f+gT )
(
y1
(
g+f
f
y1−η1
)
+
(
I∑
i=1
Xi,−T
σ2c
−σ2αh11T−1
)(
−y11T−1+B
(
I∑
i=1
Xi,−T
σ2c
−σ2αh11T−1
)))
=
1
(f+gT )
(
y21(f+g)
f
−2y1η1+
(
I∑
i=1
X
′
i,−T
σ2c
−σ2αh11
′
T−1
)
B
(
I∑
i=1
Xi,−T
σ2c
−σ2αh11T−1
))
.
Further, (
I∑
i=1
X
′
i,−T
σ2c
− l1−y1
T
1
′
T−1
)
B
(
I∑
i=1
Xi,−T
σ2c
− l1−y1
T
1T−1
)
=
(
I∑
i=1
X
′
i,−T
σ2c
− l1
T
1
′
T−1
)
B
(
I∑
i=1
Xi,−T
σ2c
− l1
T
1T−1
)
+
y1
T
1
′
T−1B
y1
T
1T−1+2
y1
T
1
′
T−1B
(
I∑
i=1
Xi,−T
σ2c
− l1
T
1T−1
)
.
We solve for each term individually. We will make use of the relationship
∑I
i=1
∑T−1
j=1
Xij
σ2c
= l1−
∑I
i=1
XiT
σ2c
. Solving
for the first term,
(∑I
i=1
X
′
i,−T
σ2c
− l1T 1
′
T−1
)
B
(∑I
i=1
Xi,−T
σ2c
− l1T 1T−1
)
=
T−1∑
j=1
(
I∑
i=1
Xij
σ2c
)2
+l21−2l1
I∑
i=1
XiT
σ2c
+
(
I∑
i=1
XiT
σ2c
)2
−2l21+2l1
I∑
i=1
Xij
σ2c
+l21−
l21
T
=
T∑
j=1
(
I∑
i=1
Xij
σ2c
)2
− l
2
1
T
.
Letting w1 =
∑T
j=1
(∑I
i=1
Xij
σ2c
)2
, the first term becomes w1− l
2
1
T . Similarly for other diagonal elements, let w2 =∑T
j=1
(∑I
i=1
Wij
σ2c
)2
and w3 =
∑T
j=1
(∑I
i=1
(XW )ij
σ2c
)2
. Solving the second term, y1T 1
′
T−1B
y1
T 1T−1, yields
=
y21
T 2
1
′
T−1(IT−1+1T−11
′
T−1)1T−1 =
y21
T 2
(
(T−1)+(T−1)1′T−11T−1
)
=
y21
T 2
(T−1+T 2−2T+1) = y
2
1
T
(T−1).
Solving for the third term, 2y1T 1
′
T−1B
(∑I
i=1
Xi,−T
σ2c
− l1T 1T−1
)
, yields
2y1
T
(1
′
T−1+(T−1)1
′
T−1)
(
I∑
i=1
Xi,−T
σ2c
− l1
T
1T−1
)
= 2y11
′
T−1
(
I∑
i=1
Xi,−T
σ2c
− l1
T
1T−1
)
= 2y1
(
−
I∑
i=1
XiT
σ2c
− l1
T
+
y1
T
− y1
T
)
= 2y1
(
y1
T
+σ2αh1−
I∑
i=1
XiT
σ2c
)
.
Substituting these terms back in the diagonal element ofM , we obtain
=
1
(f+gT )
(
y21(f+g)
f
−2y1η1+
(
I∑
i=1
X
′
i,−T
σ2c
−σ2αh11
′
T−1
)
B
(
I∑
i=1
Xi,−T
σ2c
−σ2αh11T−1
))
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=
1
(f+gT )
(
y21(f+g)
f
−2y1
(
y1+σ
2
αh1+
I∑
i=1
XiT
σ2c
)
+w1− l
2
1
T
+2y1
(
y1
T
+σ2αh1−
I∑
i=1
XiT
σ2c
)
+
y21
T
(T−1)
)
=
1
(f+gT )
(
y21
(
f+gT
fT
)
+w1− l
2
1
T
)
=
y21
fT
+
1
(f+gT )
(
w1− l
2
1
T
)
.
The second and third diagonal elements of the matrixM will have the same form.
Simplifying the off-diagonal elements ofM
To solve for the off-diagonal values, we consider one value, m21, and apply the results to the other off-diagonals. The
value of m21 is
1
(f+gT )
(
y2
(
g+f
f
y1−y1−σ2αh1+
I∑
i=1
XiT
σ2c
)
+
(
I∑
i=1
Wi,−T
′
σ2c
−σ2αh21
′
T−1
)(
−y11T−1+B
(
I∑
i=1
Xi,−T
σ2c
−σ2αh11T−1
)))
.
We will first simplify the term y2
(
g+f
f y1 − y1 − σ2αh1 +
∑I
i=1
XiT
σ2c
)
= y1y2
f+g
f − y1y2 − σ2αh1y2 +
y2
∑I
i=1
XiT
σ2c
. To simplify the second term,
(∑I
i=1
Wi,−T
′
σ2c
− σ2αh21
′
T−1
)(
−y11T−1 +B
(∑I
i=1
Xi,−T
σ2c
− σ2αh11T−1
))
,
we will break up this multiplication into different terms. The first step is multiplying two terms, yielding(
I∑
i=1
W
′
i,−T
σ2c
− σ2αh21
′
T−1
)
(−y11T−1) = −y1
T−1∑
j=1
I∑
i=1
Wij
σ2c
+ (T − 1)σ2αh2y1.
The rest of the multiplication
(∑I
i=1
Wi,−T
′
σ2c
− σ2αh21
′
T−1
)(
B
(∑I
i=1
Xi,−T
σ2c
− σ2αh11T−1
))
simplifies to
=
(
I∑
i=1
Wi,−T
′
σ2c
− l2 − y2
T
1
′
T−1
)((
IT−1 + 1T−11
′
T−1
)( I∑
i=1
Xi,−T
σ2c
− l1 − y1
T
1T−1
))
=
(
I∑
i=1
Wi,−T
′
σ2c
− l2
T
1
′
T−1 +
y2
T
1
′
T−1
)((
IT−1 + 1T−11
′
T−1
)( I∑
i=1
Xi,−T
σ2c
− l1
T
1T−1 +
y1
T
1T−1
))
=
(
I∑
i=1
Wi,−T
′
σ2c
− l2
T
1T−1
′
)((
IT−1 + 1T−11
′
T−1
)( I∑
i=1
Xi,−T
σ2c
− l1
T
1T−1
))
+
y2
T
1
′
T−1(IT−1 + 1T−11
′
T−1)
y1
T
1T−1 +
y2
T
1
′
T−1(IT−1 + 1T−11
′
T−1)
(
I∑
i=1
Xi,−T
σ2c
− l1
T
1T−1
)
+(
I∑
i=1
Wi,−T
′
σ2c
− l1
T
1
′
T−1
)
(IT−1 + 1T−11
′
T−1)(
y1
T
1T−1).
We break this multiplication up by individual terms, with the first term simplifying to(
I∑
i=1
Wi,−T
′
σ2c
− l2
T
1
′
T−1
)(
B
(
I∑
i=1
Xi,−T
σ2c
− l1
T
1T−1
))
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=
T−1∑
j=1
(
I∑
i=1
Wij
σ2c
I∑
i=1
Xij
σ2c
)
+
T−1∑
j=1
I∑
i=1
Wij
σ2c
T−1∑
j=1
I∑
i=1
Xij
σ2c
− l1
T
T−1∑
j=1
I∑
i=1
Wij
σ2c
−
l1(T − 1)
T
T−1∑
j=1
I∑
i=1
Wij
σ2c
− l2
T
T−1∑
j=1
I∑
i=1
Xij
σ2c
− l2(T − 1)
T
T−1∑
j=1
I∑
i=1
Xij
σ2c
+
l1l2(T − 1)
T 2
+
l1l2(T − 1)2
T 2
=
T−1∑
j=1
(
I∑
i=1
Wij
σ2c
I∑
i=1
Xij
σ2c
)
+
T−1∑
j=1
I∑
i=1
Wij
σ2c
T−1∑
j=1
I∑
i=1
Xij
σ2c
− l1 T−1∑
j=1
I∑
i=1
Wij
σ2c
− l2
T−1∑
j=1
I∑
i=1
Xij
σ2c
+
(T − 1)l1l2
T
= wXW −
T∑
j=1
(
I∑
i=1
Wij
σ2c
I∑
i=1
Xij
σ2c
)
− l1l2
T
, where wXW =
T∑
j=1
(
I∑
i=1
Wij
σ2c
I∑
i=1
Xij
σ2c
)
.
Let wX(XW ) =
∑T
j=1
(∑I
i=1
Xij
σ2c
∑I
i=1
(XW )ij
σ2c
)
and wW (XW ) =
∑T
j=1
(∑I
i=1
Wij
σ2c
∑I
i=1
(XW )ij
σ2c
)
for the other
off-diagonal elements. Simplifying the remaining terms,
y2
T
1
′
T−1B
y1
T
1T−1 +
y2
T
1
′
T−1B
(
I∑
i=1
Xi,−T
σ2c
− l1
T
1T−1
)
+
(
I∑
i=1
Wi,−T
′
σ2c
− l2
T
1
′
T−1
)
B(
y1
T
1T−1)
=
y1y2(T − 1)
T
+ y2
(
y1
T
+ σ2αh1 −
I∑
i=1
XiT
σ2c
)
+ y1
(
y2
T
+ σ2αh2 −
I∑
i=1
YiT
σ2c
)
.
Putting all the terms together for the off-diagonals, we get:
= y1y2
f + g
f
− y1y2 − σ2αh1y2 + y2
I∑
i=1
XiT
σ2c
− y1
T−1∑
j=1
I∑
i=1
Wij
σ2c
+ (T − 1)σ2αh2y1+
y1y2(T − 1)
T
+ y2
(
y1
T
+ σ2αh1 −
I∑
i=1
XiT
σ2c
)
+ y1
(
y2
T
+ σ2αh2 −
I∑
i=1
YiT
σ2c
)
+ wxy − l1l2
T
= y1y2
f + gT + fT
fT
− y1l2 + Tσ2αh2y1 + wxy −
l1l2
T
= y1y2
(
f + gT
fT
)
+ wxy − l1l2
T
.
Multiplying this by the constant 1f+gT , the off-diagonal element becomes
y1y2
fT +
1
f+gT
(
wxy − l1l2T
)
.
Final Algebra
We now have a simplified expression forM . To obtain (Z ′V −1Z)−122 , we calculate (Z
′V −1Z)22 −M and take the
inverse of this matrix. We have (Z ′V −1Z)22 −M equal to
=

l1 − z1 − y
2
1
fT − 1f+gT
(
w1 − l
2
1
T
)
q1 − y1y2fT − 1f+gT
(
wXW − l1l2T
)
q2 − y1y3fT − 1f+gT
(
wX(XW ) − l1l3T
)
q1 − y1y2fT − 1f+gT
(
wXW
l1l2
T
)
l2 − z2 − y
2
2
fT − 1f+gT
(
w2 − l
2
2
T
)
q3 − y2y3fT − 1f+gT
(
wW (XW ) − l2l3T
)
q2 − y1y3fT − 1f+gT
(
wX(XW )
l1l3
T
)
q3 − y2y3fT − 1f+gT
(
wW (XW )
l2l3
T
)
l3 − z3 − y
2
3
fT − 1f+gT
(
w3 − l
2
3
T
)
 .
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We can now solve for (Z ′V −1Z)−122 by taking the inverse of this 3× 3 matrix. If treatment effects are assumed
to be additive and an interaction term is not included, we can solve for the upper 2× 2 matrix for the variance-
covariance matrix of the regression coefficients for two main treatment effects. For a one treatment repeated cross-
sectional stepped wedge design, the variance of the treatment effect would be the reciprocal of the diagonal term,
l1 − z1 − y
2
1
fT − 1f+gT
(
w1 − l
2
1
T
)
, which can be shown to be the same variance as solved for by Hussey and Hughes
[1].
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